Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)

BACKGROUND: Despite the growing prevalence of opioid use among offenders, pharmacotherapy remains an underused treatment approach in correctional settings. The aim of this 4-year trial is to assess the clinical utility, effectiveness, and cost implications of extended-release naltrexone (XR-NTX, Viv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Contemp Clin Trials
Hlavní autoři: Farabee, David, Hillhouse, Maureen, Condon, Timothy, McCrady, Barbara, McCollister, Kathryn, Ling, Walter
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5550768/
https://ncbi.nlm.nih.gov/pubmed/27282118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2016.06.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky